Search Intelligence

“Internal corporate chats and operational telemetry from defunct companies are now raw material for enterprise AI tools.”

“Hacking the ear to fix the heart is a clever parlour trick that is still decades away from human trials.”

“Threatening to relocate a century-old Hollywood pillar isn't about state politics—it's a brute-force negotiation tactic to avoid bleeding quarterly delay fees before the trial even starts.”

“People keep declaring the absolute death of silicon scaling, but the dominant fabs aren't stopping—they're just quietly swapping base materials to maintain the aggressive production timelines they committed to.”

“Leadership site visits are always awkward, but walking past a massive inflatable rat and a sea of physical layoff memorials proves you can't contain structural corporate cuts to an earnings call spreadsheet.”

“They figured out they can't out-raise the American labs with venture capital alone, so they're forcing legacy European industrials to front the massive hardware bill they're on the hook for.”

“Locking out retail is just the compliance tax required to operate in Europe while exchanges wait for institutional volume to actually materialize.”

“The discovery of measurable brain damage provides a concrete biomarker for long COVID, validating symptoms for millions of patients and opening pathways for targeted clinical trials.”

“The temporary geopolitical energy spike masked a domestic economy still completely frozen by weak consumer spending and excess industrial capacity.”

“AI infrastructure spending is single-handedly saving traditional building material suppliers from a sluggish construction market.”

“Building models that autonomously find software exploits forces labs to treat their own code like hazardous material.”

“Custom AI silicon burns capital fast, giving them enough breathing room to see what industrial buyers actually jump at.”

“Promising rodent and fly models face high failure rates when transitioning to human Alzheimer's clinical trials.”

“Kashkari hasn't confirmed a formal vote yet, but floating rate hike trial balloons usually mean cheap capital isn't coming back to rescue overleveraged balance sheets.”

“Securing a thousand-unit order book from a semiconductor firm proves industrial buyers are finally writing real checks for humanoid hardware instead of just running endless pilot programs.”

“Massive multi-trillion dollar market forecasts serve primarily to justify endless capital expenditure before software revenue materializes.”

“So a $111.7 million IPO is barely enough capital to get a phase 2 oncology trial paid for.”